跳至主要内容
临床试验/ISRCTN82825745
ISRCTN82825745已完成1 期

Study to investigate the association between the response to a cholinergic challenge with galantamine and the clinical response to subsequent treatment with galantamine in patients with mild to moderate Alzheimer’s Disease

Centre for Human Drug Research0 个研究点目标入组 50 人开始时间: 2019年8月29日最近更新:
适应症

试验速览

阶段
1 期
状态
已完成
入组人数
50

研究概览

简要总结

2022 Results article in https://pubmed.ncbi.nlm.nih.gov/34964149/ (added 31/10/2022)

研究设计

研究类型
Interventional

入排标准

性别
All

入选标准

  • 1. Clinical diagnosis of AD
  • 2. Mini Mental State Examination (MMSE) score ranging from 18 to 26
  • 3. Clinical Dementia Rating (CDR) score between 0.5 and 2.0

排除标准

  • 1. Previous or current use of CEIs, anticholinergic drugs or neuroleptics
  • 2. Contraindications for the use of CEIs
  • 3. Use of benzodiazepines 48 hours prior to the study days
  • 4. History of psychiatric disorders

研究者

相似试验